Pfizer is launching seven phase 3 studies for PF-4044 soon and plans to initiate an additional 10 (at least) by the end of 2026. Pfizer clearly has big aspirations for PF-4044. Management believes the …
2 Top Dividend Stocks to Buy Now and Hold For a Decade
view original post